Atopic dermatitis (eczema) trials in Austria
1 trial · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Graz, Innsbruck, Linz, Vienna
- Age
- 12 years and over
- People
- 510 worldwide
- Run by
- Nektar Therapeutics
See details and how to joinNCT07711418EU 2025-525129-11-00Registry updated 2026-09-08
All Atopic dermatitis (eczema) trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.